Mind the Gap: A Nationwide Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Chile
- 1Hospital Alto Hospicio, Alto Hospicio 1130000, Chile;
- 2Sociedad Chilena de Infectología, Santiago 8320000, Chile; (C.C.-A.); (C.T.); (A.S.); (N.D.)
Abstract
Background: Invasive fungal infections can cause morbidity and mortality, particularly among immunocompromised and critically ill patients, making them an important global public health problem. Outcomes depend on timely diagnosis, laboratory capacity, and access to effective antifungal therapy. As national data describing these resources in Chile remain limited, we aimed to characterize national gaps in mycological diagnostic and therapeutic access. Methods: We conducted a nationwide survey of physicians, pharmacists, and laboratory professionals representing Chilean hospitals. Multiple responses from the same institution were consolidated. A 15-item diagnostic and therapeutic access score was developed to assess differences between hospitals. Results: Thirty-five hospitals participated in the survey. Diagnostic infrastructure varied substantially across institutions; all hospitals reported access to direct mycological examination, among which 65.7% had access to MALDI-TOF MS and 51.4% used molecular identification methods. The access score differed significantly according to hospital size, with median scores of 53.3% (20.0–80.0), 66.7% (46.7–86.7), and 73.3% (60.0–86.7) in hospitals with 0–300, 301–499, and ≥500 beds, respectively (p = 0.003). Conclusions: This nationwide assessment identified size-dependent inequities in mycological capacity in Chile, with larger hospitals having greater diagnostic and therapeutic access. These findings support targeted national strategies to strengthen smaller institutions and ensure equitable care.
Related
- Endoscopic Submucosal Dissection as a Diagnostic and Minimally Invasive Therapeutic Excision Modality for Primary Anorectal Malignant Melanoma
- Diabetic hand infections: a case series highlighting diagnostic and therapeutic challenges.
- Invasive Infections Caused by Streptococcus pseudoporcinus: A Two-Case Series and Review of the Literature
- Invasive Non-typhoidal Salmonella Infections in Adults: Clinical Features, Focal Disease, and Antimicrobial Resistance in a Turkish Tertiary-Care Center
- Profile of Invasive Fungal Infections in a Paediatric Haemato-Oncology Unit: A Five-Year Retrospective Cohort Study From a Tertiary Care Centre in South India
BibTeX
@article{carleo2026mind,
title = {{Mind the Gap: A Nationwide Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Chile}},
author = {Cinthia Carleo and Christian Conde-Abeliuk and Cecilia Tapia and Andrés Soto and Natalia Díaz and Mariella Raijmakers},
journal = {Journal of fungi (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/jof12100772},
url = {https://europepmc.org/article/PMC/PMC13705827},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mind the Gap: A Nationwide Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Chile
AU - Cinthia Carleo
AU - Christian Conde-Abeliuk
AU - Cecilia Tapia
AU - Andrés Soto
AU - Natalia Díaz
AU - Mariella Raijmakers
PY - 2026
DA - 2026/10/01
JO - Journal of fungi (Basel, Switzerland)
DO - 10.3390/jof12100772
UR - https://europepmc.org/article/PMC/PMC13705827
AB - Background: Invasive fungal infections can cause morbidity and mortality, particularly among immunocompromised and critically ill patients, making them an important global public health problem. Outcomes depend on timely diagnosis, laboratory capacity, and access to effective antifungal therapy. As national data describing these resources in Chile remain limited, we aimed to characterize national gaps in mycological diagnostic and therapeutic access. Methods: We conducted a nationwide survey of physicians, pharmacists, and laboratory professionals representing Chilean hospitals. Multiple responses from the same institution were consolidated. A 15-item diagnostic and therapeutic access score was developed to assess differences between hospitals. Results: Thirty-five hospitals participated in the survey. Diagnostic infrastructure varied substantially across institutions; all hospitals reported access to direct mycological examination, among which 65.7% had access to MALDI-TOF MS and 51.4% used molecular identification methods. The access score differed significantly according to hospital size, with median scores of 53.3% (20.0–80.0), 66.7% (46.7–86.7), and 73.3% (60.0–86.7) in hospitals with 0–300, 301–499, and ≥500 beds, respectively (p = 0.003). Conclusions: This nationwide assessment identified size-dependent inequities in mycological capacity in Chile, with larger hospitals having greater diagnostic and therapeutic access. These findings support targeted national strategies to strengthen smaller institutions and ensure equitable care.
SN - 2309-608X
ER -